|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kumada h"
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase
|
Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
|
Okusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H. |
| 臺大學術典藏 |
2021-09-04T06:12:08Z |
Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations
|
Ochi H.; Maekawa T.; Abe H.; Hayashida Y.; Nakano R.; Imamura M.; Hiraga N.; Kawakami Y.; Aimitsu S.; JIA-HORNG KAO; Tsunoda M.K.; Tsunoda T.; Kumada H.; Nakamura Y.; Hayes N.C.; Chayama K. |
| 臺大學術典藏 |
2021-09-04T06:11:15Z |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
|
JIA-HORNG KAO; Jensen D.M.; Manns M.P.; Jacobson I.; Kumada H.; Toyota J.; Heo J.; Yoffe B.; Sievert W.; Bessone F.; Peng C.-Y.; Roberts S.K.; Lee Y.-J.; Bhore R.; Mendez P.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T06:11:09Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak R.; Kawazoe S.; Znoyko O.; Assy N.; Gadano A.; JIA-HORNG KAO; Lee K.-S.; Zwirtes R.; Portsmouth S.; Dong Y.; Xu D.; Kumada H.; Srinivasan S. |
| 臺大學術典藏 |
2021-08-05T02:39:56Z |
Biomolecule-Assisted Synthesis of Hierarchical Multilayered Boehmite and Alumina Nanosheets for Enhanced Molybdenum Adsorption
|
Saptiama I;Kaneti Y.V;Yuliarto B;Kumada H;Tsuchiya K;Fujita Y;Malgras V;Fukumitsu N;Sakae T;Hatano K;Ariga K;Sugahara Y;Yamauchi Y.; Saptiama I; KEVIN CHIA-WEN WU et al. |
| 國立成功大學 |
2019 |
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
|
Wei, L.;Kumada, H.;Perumalswami, Perumalswami P.V.;Tanwandee, Tanwandee T.;Cheng, W.;Heo, J.;Cheng, P.-N.;Hwang, P.;Mu, S.M.;Zhao, X.M.;Asante-Appiah, E.;Caro, L.;Hanna, G.J.;Robertson, M.N.;Haber, B.A.;Talwani, R. |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak, R.;Kawazoe, S.;Znoyko, O.;Assy, N.;Gadano, A.;Kao, J.-H.;Lee, K.-S.;Zwirtes, R.;Portsmouth, S.;Dong, Y.;Xu, D.;Kumada, H.;Srinivasan, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations
|
Ochi, H.; Maekawa, T.; Abe, H. ;Hayashida, Y.; Nakano, R.; Imamura, M. ;Hiraga, N. ;Kawakami, Y. ;Aimitsu, S.; Kao, J.H. ;Tsunoda, M.K.; Tsunoda, T.; Kumada, H.; Nakamura, Y.; Hayes, N.C. ;Chayama, K.; JIA-HORNG KAO |
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
